Integra Lifesciences Holdings (IART) Gross Margin (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Gross Margin of 52.47% for Q2 2026, down 5.22% sequentially from 55.36% in Q1 2026, and up 211.0% YoY from 16.87% in Q2 2025.
Integra Lifesciences Holdings (IART) Gross Margin (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Gross Margin for 18 years, with the latest figure at 52.47% in Q2 2026.
- Quarterly Gross Margin rose 211.0% year-over-year to 52.47% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 52.47% (down 13.0% YoY) and the FY2025 annual result came in at 50.86%, down 391.0% from the prior year.
- Gross Margin retreated to 52.47% in Q2 2026 per IART's latest filing, from 55.36% in the prior quarter.
- Over five years, Gross Margin peaked at 62.83% in Q4 2022 and troughed at 50.37% in Q2 2025.
- A 5-year average of 56.05% and a median of 55.72% in 2024 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2023 and 2026: Gross Margin plunged 840 bps in 2023, then soared 455 bps in 2026.
- Over 5 years, Gross Margin stood at 62.83% in 2022, then declined by 9 bps to 57.05% in 2023, then retreated by 1 bps to 56.27% in 2024, then dropped by 10 bps to 50.78% in 2025, then rose by 3 bps to 52.47% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 52.47%, 55.36%, and 50.78% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 45.84% |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 52.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.47% |
| Mar 31, 2026 | 55.36% |
| Dec 31, 2025 | 50.78% |
| Sep 30, 2025 | 51.48% |
| Jun 30, 2025 | 50.37% |
| Mar 31, 2025 | 50.81% |
| Dec 31, 2024 | 56.27% |
| Sep 30, 2024 | 52.58% |
| Jun 30, 2024 | 54.02% |
| Mar 31, 2024 | 56.07% |
| Dec 31, 2023 | 57.05% |
| Sep 30, 2023 | 57.10% |
| Jun 30, 2023 | 54.30% |
| Mar 31, 2023 | 61.15% |
| Dec 31, 2022 | 62.83% |
| Sep 30, 2022 | 61.46% |
| Jun 30, 2022 | 62.70% |
| Mar 31, 2022 | 62.15% |
| Dec 31, 2021 | 61.47% |
| Sep 30, 2021 | 62.66% |